Journal article

Antimalarial chemoprophylaxis for forest goers in southeast Asia: an open-label, individually randomised controlled trial

Abstract:: Background: Malaria in the eastern Greater Mekong subregion has declined to historic lows. Countries in the Greater Mekong subregion are accelerating malaria elimination in the context of increasing antimalarial drug resistance. Infections are now increasingly concentrated in remote, forested foci. No intervention has yet shown satisfactory efficacy against forest-acquired malaria. The aim of this study was to assess the efficacy of malaria chemoprophylaxis among forest go...
Expand abstract
Collapse abstract

Publication status:: Published

Peer review status:: Peer reviewed

Actions

Email

Email this record

Send the bibliographic details of this record to your email address.

Your Email
Please enter the email address that the record information will be sent to.

-
Your message (optional)
Please add any additional information to be included within the email.
Share
Cite

Cite this record

APA Style

Tripura, R., von Seidlein, L., Sovannaroth, S., Peto, T., Callery, J., Sokha, M., Ean, M., Heng, C., Conradis-Jansen, F., Madmanee, W., Peerawaranun, P., Waithira, N., Khonputsa, P., Jongdeepaisal, M., Pongsoipetch, K., Chotthanawathit, P., Soviet, U., Pell, C., Duanguppama, J., … Maude, R. (2022). Antimalarial chemoprophylaxis for forest goers in southeast Asia: an open-label, individually randomised controlled trial. Lancet Infectious Diseases, 23(1), 81–90.

MLA Style

Tripura, R., et al. “Antimalarial Chemoprophylaxis for Forest Goers in Southeast Asia: An Open-Label, Individually Randomised Controlled Trial.” Lancet Infectious Diseases, vol. 23, no. 1, 2022, pp. 81–90.

Chicago Style

Tripura, R., L. von Seidlein, S. Sovannaroth, et al. 2022. “Antimalarial Chemoprophylaxis for Forest Goers in Southeast Asia: An Open-Label, Individually Randomised Controlled Trial.” Lancet Infectious Diseases 23 (1): 81–90.
Print

Access Document

Files:: Tripura_et_al_2022_antimalarial_chemoprophylaxis_for.pdf

(Preview, Version of record, pdf, 516.8KB, Terms of use)

Publisher copy:: 10.1016/s1473-3099(22)00492-3

Authors

+ Tripura, R More by this author

Role:: Author

+ von Seidlein, L More by this author

Role:: Author

+ Sovannaroth, S More by this author

Role:: Author

+ Peto, TJ More by this author

Role:: Author

+ Callery, JJ More by this author

Role:: Author

More authors...

Publisher:: Elsevier
Journal:: Lancet Infectious Diseases More from this journal
Volume:: 23
Issue:: 1
Pages:: 81-90
Place of publication:: United States
Publication date:: 2022-09-26
Acceptance date:: 2022-07-11
DOI:: 10.1016/s1473-3099(22)00492-3
EISSN:: 1474-4457
ISSN:: 1473-3099
Pmid:: 36174595

Language:: English
Keywords:: FFR
Pubs id:: 1280457
Local pid:: pubs:1280457
Deposit date:: 2022-11-08
ARK identifier:: ark:/29072/ora_9fded1ebfef2483791ed6c8f754f8bb5

Terms of use

Copyright holder:: Tripura et al
Copyright date:: 2022
Rights statement:: © 2022 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license.

Licence:: CC Attribution (CC BY)

Views and Downloads

Views and downloads will return soon

If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP